
CAS 1096708-71-2
:Formula:C17H12Cl2F3N7O2S
InChI:InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1
InChI key:VWMJHAFYPMOMGF-ZCFIWIBFSA-N
SMILES:C[C@H](C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Tovorafenib
CAS:(R)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamideFormula:C17H12Cl2F3N7O2SPurity:99%Molecular weight:506.29TAK-580
CAS:TAK-580 (MLN2480) is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.Formula:C17H12Cl2F3N7O2SPurity:99.60% - 99.77%Color and Shape:White SolidMolecular weight:506.289MLN2480
CAS:Controlled ProductApplications MLN2480 is a RAF inhibitor that is used for the treatment of melanoma.
Formula:C17H12Cl2F3N7O2SColor and Shape:NeatMolecular weight:506.29BIIB-024
CAS:BIIB-024 is a monoclonal antibody that targets mutant melanoma cells. It binds to the tumor and prevents it from growing, as well as preventing the cancer cells from spreading. BIIB-024 has shown effectiveness in clinical studies by reducing tumor size and skin reactions in patients with melanoma. The effective dose of BIIB-024 is 10 milligrams per kilogram of body weight. BIIB-024 also inhibits protein synthesis in tumor cells, which may be due to its ability to bind to cytosolic proteins.
Formula:C17H12Cl2F3N7O2SPurity:Min. 95%Molecular weight:506.29 g/mol4-Pyrimidinecarboxamide, 6-amino-5-chloro-n-[(1r)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-
CAS:Formula:C17H12Cl2F3N7O2SPurity:99%Color and Shape:SolidMolecular weight:506.2891







